Podcast Episode Details
Back to Podcast Episodes
EPS #269 | Novo Nordisk Earnings, Kimberly-Clark Buys Kenvue, & Our Update on monthly dividend portfolio
Season 269 Episode 6
In this week’s episode of Dividend Talk we kick off with Kimberly-Clark’s surprise move to buy Kenvue, asking if it’s a smart acquisition or a future balance-sheet headache. Then we review Q3 earnings from Novo Nordisk, Wolters Kluwer, and Ahold Delhaize, three European dividend powerhouses facing very different challenges.
Novo Nordisk’s obesity drugs, valuation reset, and dividend safety dominate the discussion, while Wolters Kluwer’s high-PE sell-off and the impact of AI on research businesses spark debate on fair value and buybacks. We also look at Snap-on’s double-digit dividend hike and Simon Property Group’s steady income growth for REIT investors.
Later, we revisit our “Monthly Dividend Portfolio” challenge from 2022, checking how picks like Altria, AbbVie, Johnson & Johnson, Realty Income, Shell, and Texas Instruments performed with lessons on dividend growth, yield, and diversification.
In the listener Q&A, we cover:
Dividend tax strategies and EU exit taxes
How to handle rising wealth taxes as a dividend investor
Fair-value analysis vs Morningstar valuations
Our take on Volkswagen, General Mills, GreenCoat UK, ExxonMobil vs Chevron, and the global renewable-energy transition
Thoughts on Unilever’s upcoming Magnum spinoff
SEE YOU ON THE INSIDE!!
Tickers discussed: KMB, KVUE, NVO, LLY, PFE, WKL.AS, AD.AS, SNAP-ON, SPG, MO, ABBV, JNJ, O, TXN, SHEL, GIS, XOM, CVX, UKW.L
Join us:[Facebook] – Https://www.facebook.com/groups/dividendtalk
[Twitter] – @DividendTalk_ , @European_DG
[Discord] – https://discord.gg/nJyt9KWAB5
[Premium Services] – https://dividendtalk.eu/download-your-free-samples/
[Malmo Meetup] – https://t.co/STgV1nMWKj
Published on 16 hours ago